IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Gabriele Bazzocchi, M.D., PhD, A.G.A.F. Neuro-Gastroenterology and G.I. Rehabilitation Unit Montecatone Rehabilitation Institute Imola (Italy) Milano, 25 Novembre 2019 IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA’ INTESTINALE NEL PAZIENTE CON SCI
Intestinal evacuation is direct consequence of the propagating contractions (HAPC) action Repeated HAPC associated with an urge to defecate and the defecation Bazzocchi G et al. Gastroenterology 1991; Herbst F et al. GUT 1997; 41: 381-389
Propagating High Amplitude Contractions (HAPC) induce the principal ab-oral transport of the intraluminal colonic contents Rapid scintigraphic scans (1-min interval) showing transport from the right colon into the rectum during HAPC min +67 +68 +69 Bazzocchi G et al. Gastroenterology 1991
Colorectal transport during defecation in subjects with supraconal spinal cord injury Rasmussen MM et al. Spinal Cord 2013; 51: 683- 7 Normal subject Before defecation After defecation
The Guinea-pig proximal colon, colonic flexure, and distal colon, removed from freshly killed animal and showing the normal appearance of fecal contents Costa M et al. Neurogastroenterol Motil 2015
THE ENTERIC NERVOUS SYSTEM: THE SECOND BRAIN ~ 50 transmitters / modulators / messengers (i.e. amines, neuropeptides, gases, etc…) ~ 20 subclasses of functionally distinct neurons (i.e. IPANS, interneurons, motorneurons, etc…) various integrated reflex pathways (i.e. Peristalsis, MMC, secretomotor reflexes, etc…) neuroplasticity (i.e. maintenance and repair) De Giorgio R., et al., TiPS, 2007; 28:473-81 submucous plexus as a third and distinct division of the myenteric Autonomic Nervous System along with 5x 108 neurons (humans) plexus the sympathetic and parasympathetic divisions Camilleri M et al. Nature Reviews 2017
MECHANISMS UNDERLYING COLONIC MOTOR PATTERNS Spencer NJ et al. J Physiol 2016; 594: 4099-4116 Mechanosensory enteric neurons have essential mechanosensitive nerve endings in the circular muscle. Distension or stretch of the colon activates these sensory neurons to initiate polarized neural pathways that result in oral contraction and anal relaxation. These pathways do not require the mucosa but can be modulated by sensory nerve endings that project into the mucosa. The polarized enteric circuits form the bases of a neuromechanical loop which ensures that polarized enteric neural circuitry can efficiently propel content with a wide range of physical properties.
NEUROMECHANICAL FACTORS INVOLVED IN THE FORMATION AND PROPULSION OF FECAL PELLETS IN THE GUINEA-PIG. PROPULSION IS NOT A SIMPLE Costa M et al. Neurogastroenterol Motil 2015 REFLEX BUT RATHER A MORE COMPLEX PROCESS INVOLVING AN ADAPTABLE NEUROMECHANICAL LOOP ……..BOLUS SIZE AND CONSISTENCY AFFECTS PROPULSION SPEED…
Factors associated with successful decrease and discontinuation of Antegrade Continence Enemas (ACE) in children with defecation disorders: a study evaluating the effect of ACE on colonic motility Colon motility tracing demonstrating improvement of HAPCs: (A): Normalization of HAPCs from partial to full propagation (B): Normalization of HAPCs from absent to full propagation Liem O et al. Neurogastroenterol Motil 2010
COLONIC MOTILITY DURING RECTOCLYSIS irrigation
PATIENTS 16 SCI pts, 10 tetraplegic, ASIA A post-traumatic lesion 50 cms 40 cms 20 cms Intraluminal pressure recording points 10 cms 30 cms Internal Anal Sphincter 30 min later manometric probe was placed into the colonic lumen, a Trans Anal Irrigation procedure using Peristeen® device was performed according to the following protocol: Bazzocchi G et al. Pelviperineology 2012; 31: 85-92
LEFT COLON MANOMETRY during TRANS ANAL IRRIGATION 50 cm 40 cm 30 cm 20 cm 10 cm SAI Catheter balloon Irrigation initiation water Bazzocchi G et al. Pelviperineology 2012; 31: 85-92
Abdominal x-ray film in a Abdominal x-ray film in the pts with SCI after 6 days previous patient (CF) after where 10 radioopaque only one markers were taken daily. TRANS ANAL IRRIGATION session Patient (CF) had only 1 by means of Peristeen bowel movement during study week
Transanal irrigation Before irrigation After irrigation Anterior view of the 111In-labeled bowel content before washout (A) and after (B): the colon is empty anal to the left colic flexure Christensen P et al. Dis Colon Rectum 2003: 46:68-76
Laboratory animals are tetrapedal They do not stop normal activity to defecate They do not adopt a defecatory posture Humans normally retain feces and defecate only intermittently Differences in the structure and functional characteristics of the pelvic floor of humans compared with tetrapods reflect its important role in continence imposed by an upright posture
Constipation Pelvic Floor Musculature At rest Straining to defecate Symphysis pubis Coccyx Anorectal angle Anorectal Puborectalis angle Rectum External anal sphincter Descent of pelvic floor
The nerve pathways for voluntary control of defecation and fecal continence GUT innervation by ANS ce BN: Barrington’s nucleus; LCG: Lateral Cell Group; IML: InterMedioLateral column; ENS: Enteric Nervous System; Pelv gang: pelvic ganglia; 2 ord: second order neurons; ON: Onuf’s nucleus
NORMAL COLONIC MOTILITY NORMAL ANORECTAL SENSATION NORMAL DEFECATION NORMAL RECTAL EXPULSION FORCE
NORMAL ANORECTAL NORMAL COLONIC MOTILITY SENSATION NORMAL DEFECATION COORDINATED NORMAL RECTAL ABDOMINAL- PELVIC EXPULSION FORCE and PERINEAL NEUROMUSCOLAR FUNCTION TO EVACUATE
NORMAL COLONIC MOTILITY NORMAL ANORECTAL SENSATION NORMAL DEFECATION COORDINATED NORMAL RECTAL ABDOMINAL- PELVIC EXPULSION FORCE and PERINEAL NEUROMUSCOLAR FUNCTION TO EVACUATE NORMAL Colonic intraluminal content:
GUT MICROBIOTA: THE MOST DENSE AND COMPLEX BACTERIAL ECOSYSTEM ON THE PLANET EARTH Bengmark S. Gut 1998 Sender R et al. PLoS Biol 2916 BACTERIA ARE THE MAJOR COMPONENT 200 billions/g → OF FORMED STOOL contributing of 0.5-1.0 kg of the average adult’s body weight
CONSTIPATION CAN BE THE CONSEQUENCE OF DISTURBANCE OF THE MICROBIOTA BALANCE Quigley EMM. The enteric microbiota in the pathogenesis and management of constipation. Best Practice &Research Clinical Gastroenterology 2011 Rhee SH et al. Principles and clinical implications of the Brain-Gut-Enteric Microbiota Axis. Nature Reviews Gastroenterology & Hepatology 2009 Quigley EMM et al. Constipation and the microbioma: lumen versus mucosa. Gastroenterology 2016; 150: 300-303 “AN EMPY COLON HAS NO MOTOR ACTIVITY” Costa M et al. Am J Physiol Gastrointest Liver Physiol 2013
IN PTS WITH SLOW TRANSIT CONSTIPATION HAPC OCCURRENCE IS SIGNIFICANTLY REDUCED AFTER MEAL (M) AND DURING AWAKENING (A) Bazzocchi G et al. Gastroenterology 1991; 98: 686-93 Bassotti G et al. World J Gastroenterol 2005; 11: 2691-6.
Neurogastroentero Motil 2011
There were no HAPC observed in the SCI group during pre-sleep, sleep, and post-sleep phases. All non-SCI subjects experienced subjective symptoms (e.g. sensation of flatus) and two had bowel movements in close proximity to having HAPC in the post-sleep phase.
Abdominal X-RAY in ♀ with p.t. paraplegia
Scintigraphic study showing defecation produces a complete emptying of the left colon in normal subjects, but not in SCI Before defecation After defecation Normal (Score = 81 (53-140) SCI (Score = 27 (0-44) Rasmussen MM et al. Spinal Cord 2013; 51: 683- 7
COLONIC TRANSIT STUDY WITH RADIOPAQUE MARKERS IN A PATIENT WITH P.T. PARAPLEGIA Patient reported daily bowel movements during the 7 day study period. N° of markers ingested = 60 N° of markers in the large bowel on the 7th day = 53 Total Transit Time = 127.2 hours (n.v.
COLONIC TRANSIT in SCI: differentiate transport for fluid and hard stool through the large bowel Radiopaque markers are not inserted in the formed/hard stools
Pathophysiology of Bowel Dysfunction in Spinal Cord Injury There are intrinsic factors associated with the injury itself which disrupt normal motor and sensory functions within the g.i. tract. Additional external factors may influence bowel disorders. Qi Z et al. Bowel management in Spinal Cord Injury. Curr Gastroenterol Rep 2018
BOWEL DYSFUNCTION in SCI - GENERAL DECREASE IN MOTOR DELAYED COLONIC ACTIVITY IN THE COLONIC TRACTS TRANSIT TIME (LACK OF HAPC?) - VISCERAL SENSORY LOSS - ABDOMINAL MUSCLE INCOMPLETE INSUFFICIENCY EVACUATION ANORECTAL - DEFECT IN THE STRIATED OUTLET MUSCLE CONTROL - RECTO-ANAL INHIBITORY DYSFUNCTION REFLEX IS MAINTAINED FORMATION OF POST- EVACUATION FECAL NOT SCHEDULED RESIDUES AND THEIR (UNWANTED) ACCUMULATION DEFECATION FECAL INCONTINENCE/ SOILING FECAL IMPACTION IN THE LARGE BOWEL
Management of neurogenic bowel dysfunction manifesting as constipation and fecal incontinence Qi Z et al. Bowel management in Spinal Cord Injury. Curr Gastroenterol Rep 2018
Management of neurogenic bowel dysfunction manifesting as constipation and fecal incontinence Antispasmodics Antimeteorics Prebiotics Probiotics Synbiotics Antibiotics
Management of neurogenic bowel dysfunction manifesting as constipation and fecal incontinence loperamide? anal plugs? Cholestyramine Antispasmodics Antimeteorics Prebiotics Probiotics Synbiotics Antibiotics
FECAL RETENTION / COPROSTASIS / CONSTIPATION Colonic hypo-dysmotility DISORDERS of PERISTALSIS Decrease of HAPC Diseases of the Enteric Nervous System Disorders of retrograde propulsion Changes in regulation by external signals Alterations in regional wall tone Reduced fecal volume and changes in stool consistency
FECAL RETENTION / COPROSTASIS / CONSTIPATION Colonic hypo-dysmotility MEDICAL and REHABILITATION APPROACH - Poliethylene glycol (macrogol) - Stimulant laxatives: sodium picosulphate, bisacodyl, sennosides - Prokinetic drugs: prucalopride, linaclotide, neostigmine, trimebutine - Water consumption (!??) - Dietary (hydrosoluble) fiber supplementation - Prebiotics - Probiotics, symbiotics - Lactulose, lactilole - Digital rectal stimulation - Abdominal massage - Mechanical distention of the colonic wall: COLONIC IRRIGATION SURGERY ?
Physical factors in the stimulation of colonic peristalsis Hardcastle JD, Mann CV. Gut 1970; 11: 41-46
Bisacodyl and High-Amplitude-Propagating Colonic Contractions in Children Hamid SA, Di Lorenzo C, Reddy SN, Alex F, Hyman P . J Pediatr Gastroenterol Nutr 1998
POLYETHYLENE GLYCOL solution MACROGOL 3350/electrolyte improves constipation in Parkinson’s disease and multiple system atrophy Eichhorn TE, Oertel WH. Mov Disord 2001; 16: 1176-7 Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Corazziari E, Badiali D, Bazzocchi G et al. Gut 2000; 46:522-6. Polyethylene glycol solution in subgroups of chronic constipation patients: experience in obstructed defecation. Bazzocchi G. Ital J Gastroenterol Hepatol 1999; 31: S257-9
PRODOTTI a base di PEG NOME (AIC) FORMULAZIONE INDICAZIONE MOVICOL 20 buste (1 in 125 ml) Stipsi cronica idiopatica PEG 3350 (13,125 g) + E (NaCl, e secondaria; fecaloma (Norgine) KCl, Ca2Na) MOVICOL Stipsi cronica idiopatica SENZA AROMA 20 buste (1 in 125 ml) e secondaria; fecaloma (Norgine) PEG 3350 (13,125 g) + E MOVICOL Flacone da 500 ml Stipsi cronica idiopatica CONCENTRATO PEG 3350 (13,125 g) + E e secondaria (Norgine) MOVICOL SOLUZIONE 20 buste da 25 ml Stipsi cronica idiopatica ORALE e secondaria; fecaloma PEG 3350 (13,125 g) + E (Norgine) MOVICOL 20 buste (1 in 62,5 ml) Stipsi cronica nei BAMBINI PEG 3350 (6.9 g) + E bambini da 2 a 11 anni. Fecaloma nei bambini (Norgine) sopra i 5 anni. MOVICOL Stipsi cronica nei 20 buste (1 in 62,5 ml) bambini da 2 a 11 anni. BAMBINI PEG 3350 (6.9 g) + E Fecaloma nei bambini SENZA AROMA sopra i 5 anni. (Norgine)
PRODOTTI a base di PEG NOME (AIC) FORMULAZIONE INDICAZIONE SELG 250 16 buste (1 in 250 ml) Trattamento della stitichezza (Alfa Wassermann) PEG 4000 (14,8 g) Bambini di peso superiore + E + solfato di sodio ai 20Kg ISOCOLAN 8 buste (1 in 250 ml) Trattamento della stitichezza (Zambon) PEG 4000 (17,4) + E + solfato di sodio COLIREI 16 buste (1 in 250 ml) Pulizia dell’intestino prima di indagini diagnostiche o Abc (in concessione interventi chirurgici sul a Sofar) PEG 4000 (14,8 g) colon-retto. Trattamento + E + solfato di sodio saltuario della stipsi funzionale. PERGIDAL 20 buste (1 in 125 ml) Trattamento della stitichezza (Valeas) PEG 4000 (7,3 g) + E + solfato di sodio
PRODOTTI a base di PEG NOME (AIC) FORMULAZIONE INDICAZIONE PAXABEL 20 BUSTE Trattamento sintomatico della (Ipsen) stipsi nell’adulto e nel PEG 4000 (10 g) (1 in 125 ml) bambino (6 mesi – 8 anni) PEG 4000 (4 g) (1 in 50 ml) LAXIPEG Polvere barattolo 200g Trattamento di breve durata della (Zambon) stitichezza 20 buste 9,7 g occasionale PEG 4000 REGOLINT Polvere barattolo 200 grammi Trattamento della stitichezza nel (Baldacci) bambino 20 buste da 9,7 grammi Trattamento di breve durata della PEG 4000 stitichezza occasionale CASENLAX 20 buste 10g Trattamento sintomatico della (Recordati) stipsi PEG 4000
ULTIMEa NOVITA’ PRODOTTI base di PEG NOME (AIC) FORMULAZIONE INDICAZIONE ONLIGOL 20 BUSTE 10g Stitichezza cronica o intestino occasionalmente (Alfawassermann) irregolare Flacone polvere 400g Dispositivo Medico PEG 4000 SANIPEG 300g barattolo Trattamento sintomatico 20buste 4g della stipsi Sanitas 20 buste 10 Dispositivo Medico PEG (non specificato) CLIN 4000 Barattolo 200g Stitichezza cronica o 30buste 10g intestino occasionalmente Akkadeas irregolare PEG 4000 Dispositivo Medico MACROGOL 20 buste 13,8g Stitichezza cronica; GENERICI fecaloma PEG 3350 + E Mylan (Goganza)/ Sandoz/ Carlo Erba….
A safe and effective multi-day colonoscopy bowel preparation for individuals with spinal cor injuries Song SH et al. J Spinal Cord Med 2018 Day 1: - Start clear liquid diet at dinner - Magnesium citrate 480 ml after dinner Day2: - Continue clear liquid diet - PEG 3350 and electrolyte colonic lavage solution (PEG-ELS) 4L over 2 hours in the morning Day 3: - Continue clear liquid diet until midnight, then nothing per os - PEG-ELS over 2 hours in the morning Day 4: - Is rectal/colostomy output clear? YES NO READY FOR COLONOSCOPY PEG-ELS 2L PRIOR COLONOSCOPY
Colonic intraluminal contents have a sub- stantial effect on colonic transit In female controls bowel cleansing shortened rectosimoid transit Women with constipation had faster transit in the cleansed state, however, the distribution of markers was not altered: DELAYS in TRANSIT TIME were still present in the same colonic tract
PROKINETICS DRUGS Neostigmine Prucalopride Linaclotide Cisapride Domperidone Trimebutine Levolsulpiride Erythromycin Misoprostol
Neostigmine reduced the time to first flatus, time to start of bowel movement, time to end of bowel movement, and time for total bowel care as compared to placebo INTRASTIGMINA f. 1 ml, 0.5 mg TID
PRUCALOPRIDE 2 mg significantly reduced total colonic transit time in patients with supraconal SCI This reduction in transit time was also associated with an increase in the weekly frequency RESOLOR 2 mg cpr, 1 cpr 5 hours before scheduled evacuation
Effect of 5 days linaclotide on transit and bowel function in females with constipation- predominant Irritable Bowel Syndrome. Andresen V. et al. Gastroenterology 2007; 133: 761-8 CONSTELLA 290 mg, caps, 30 min before breakfast or lunch
PROKINETICS DRUGS Neostigmine Prucalopride Linaclotide Cisapride Domperidone Trimebutine Levolsulpiride Erythromycin Misoprostol
- Intravenous administration of 100 mg trimebutine was followed,
Poynard T. et al. TRIMEBUTINE and IBS META-ANALYSIS OF SMOOTH MUSCLE RELAXANTS IN THE TREATMENT OF IBS -1888 pts, 23 randomized clinical trials - global assessment, pain, abdominal distension, constipation improved significantly with cimetropium, mebeverine, otilonium, pinaverium and trimebutine APT 2001; 15: 355-61 Rahman MZ et al. COMPARATIVE EFFICACY AND SAFETY OF TRIMEBUTINE VERSUS MEBEVERINE IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME -IBS-QOL was assessed in 122 pts with IBS before and after 6 weeks of treatment with trimebutine 100 mg b.i.d. or mebeverine 135 mg b.i.d. - QOL score decreased from 103 to 82 in trimebutine and from 106 to 95 in mebeverine group: improvement in both groups was statistically significant, as the difference between the two groups. Mymensingh Med J 2014; 23: 105-13
LEVOSULPIRIDE IN IBS Lanfranchi GA, Bazzocchi G, Marzio L et al. INHIBITION OF POSTPRANDIAL COLONIC MOTILITY BY SULPIRIDE IN PATIENTS WITH IRRITABLE COLON - administration of sulpiride 100 mg i.m. significantly reduced the postprandial increase in colonic motor activity - dopaminergic receptors may be involved in the colonic motor response to food Eur J Clin Pharmacol 1983; 769: 772
LEVOSULPIRIDE IN IBS - Levosulpiride 25 mg t.i.d. for 10 days accelerate colonic transit time more than placebo in 20 pts with Functional Constipation or IBS
- Levosulpiride was better than domperidone in improving 6 out of 10 recorded symptoms, and was better than metoclopramide in improving 6 out of 10 selected symptoms anorexia nausea vomiting upper abdominal pain postprandial bloating abdominal fullness early satiety belching heartburn regurgitation LEVOSULPIRIDE 25 mg 30 min before meals
Advantages of Azithromycin Over Erythromycin in Improving the Gastric Emptying Half-Time in Adult Patients With Gastroparesis Jean M Larson et al. J NEUROGASTROENTEROL MOTIL 2010; 16: 407-413 Erythromycin 250 mg f, 1 f i.v. TID ERITROCINA 200 mg cpr masticabili ERITROCINA 10% granulato sosp orale
CYTOTEC 200 µg, 2 cpr TID
QUESTRAN 4 gr polvere x sosp orale, 1 busta ad ogni pasto
Management of neurogenic bowel dysfunction manifesting as constipation and fecal incontinence loperamide? anal plugs? Cholestyramine Antispasmodics Antimeteorics Prebiotics Probiotics Synbiotics Antibiotics
Primary endpoints: - bowel evacuations with normal stool consistency - Intestinal Transit Time Secondary endpoints: - Symptoms according to Rome III Diagnostic Criteria - Agachan-Wexner score - Changes in gut microbiota composition
abdominal bloating No effect on pain, gas, urgency flatulence colonic transit Mean BSFS scores and CSBMs/week increased in FC
GUT DYSBIOSIS IMPAIRS RECOVERY AFTER SPINAL CORD INJURY In mice with experimental SCI, the pre-existence of intestinal dysbiosis caused larger lesions to form after injury. Kigerl KA et al. J Experim Med 2016; 213: 2603-20 Probiotics (VSL#3) confer neuroprotection and improve locomotor recovery after SCI In an effort to develop a clinically feasible therapeutic protocol, SCI mice received VSL#3 probiotics starting immediately after injury and then again daily until 35 dpi. In VSL#3-treated SCI mice, locomotor recovery was significantly improved relative to vehicle-treated SCI mice. VSL#3 increased the frequency of plantar stepping and fore limb–hind limb coordination with concomitant improvements in paw position and trunk. VSL#3 also reduced lesion volume and axon/myelin pathology at the injury epicenter. Smaller lesion volumes in the VSL#3-treated mice correlated with improved behavioral recovery.
Alpha diversity (i.e. biodiversity) of the GUT MICROBIOTA from 100 pts with SCI and 100 healthy subjects matched for age and sex. A stool sample was collected during the first week after admission to 10 Spinal Units scattered all over the Italian territory p=0.001 ***
Diversity of the GUT MICROBIOTA structure Diversity of the GUT MICROBIOTA between pts showing greater severity of STRUCTURE between pts with AIS score A the SCI (cervical or thoracic lesional level or B vs pts with AIS score C or D with AIS score A or B) vs pts with minor severity (AIS score C or D or lumbar level) p=0.029* p=0.036 *
Fecal microbiota transplantation in spinal cord injury. Brechmann T et al. WJG 2015 Amount of fresh feces prepared for infusion or infused fecal suspension: from 30 to 250 g of fresh stool in 30 to 700 mL. Number of FMT regimens: from single treatments to 14
TAKE HOME MESSAGE Gli studi che valutano efficacy/safety di farmaci potenzialmente utili nel trattamento dei disturbi intestinali dopo mielolesione sono ancora troppo pochi L’evidenza di un overlap tra la disfunzione intestinale nella persona con patologie del SNC e quella della popolazione con disturbi «funzionali» autorizza all’impiego di numerosi farmaci per ben specificati obiettivi terapeutici Per le specificità, in termini di complessità dei problemi e tempi, del trattamento medico/riabilitativo di cui necessita una persona con SCI, i Prontuari Ospedalieri di cui siamo dotati non sono adeguati La cura della disfunzione intestinale dopo SCI mostra di essere cruciale ai fini della morbidità e QoL di questi pazienti
You can also read